NIH-funded research R01 grant

Dual-modality ultrasound and photoacoustic imaging to improve prostate cancer detection

Official title: Clinical Translation of dual-modality transrectal ultrasound and photoacoustic imaging for detection of aggressive human prostate cancer

Funded at Pennsylvania State University, the · NIH-11174469 · Data updated 2026-11-12

A new imaging approach combines ultrasound and light-based imaging to better identify aggressive prostate cancer in American men.

More Prostate Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPennsylvania State University, the
NIH-funded
Lab location1 site (University Park, United States)
Project startSeptember 19, 2023
Project endApril 30, 2029
Funding year2026
Award (this year)$645,704
NIH project number5R01CA278833-03
Project IDNIH-11174469 on NIH RePORTER

Who could benefit from this research

Could help

American men at risk for or suspected of having prostate cancer, undergoing diagnostic evaluation for tumor aggressiveness.

Less likely to help

Individuals without prostate cancer or with non-aggressive disease may not benefit from this imaging approach.

What this research studies

This project aims to create a TRUSPA imaging platform that merges transrectal ultrasound with photoacoustic imaging to non-invasively map functional and molecular features of the prostate. By conducting multi-institutional development and translation, it seeks to differentiate aggressive from non-aggressive tumors and reduce under-sampling during biopsy. The work builds on prior TRUSPA experience and focuses on delivering a clinically viable tool for more accurate diagnosis. Participants would contribute imaging data and, potentially, biopsy samples to validate the technology’s performance.

Why it matters

Potential benefit: If successful, patients may experience more accurate diagnosis of aggressive prostate cancer, guiding better treatment decisions.

How similar studies have gone: Earlier TRUSPA imaging work has shown promise in mapping tumor biology and improving diagnostic accuracy, though broader validation is ongoing.

Where this research is happening

  • Pennsylvania State University, the
    University Park, United States
    Active

Researchers

  • Principal investigator: Kothapalli, Sri Rajasekhar — Pennsylvania State University, the
  • Study coordinator: Kothapalli, Sri Rajasekhar

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.